3082B |
Molindone, Blood |
3082SP |
Molindone, Serum/Plasma |
3082U |
Molindone, Urine |
3157U |
Cotinine and Anabasine from Secondary Exposure, Urine |
3225SP |
Nuedexta®, Serum/Plasma |
3226B |
Olanzapine and Metabolite, Blood |
3226FL |
Olanzapine, Fluid |
3226SP |
Olanzapine and Metabolite, Serum/Plasma |
3226TI |
Olanzapine, Tissue |
3250SP |
Oxalate, Serum/Plasma |
3371SP |
PCB Panel, Congeners, Serum/Plasma |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3440B |
Perphenazine, Blood |
3440SP |
Perphenazine, Serum/Plasma |
3776B |
Pimozide, Blood |
3776SP |
Pimozide, Serum/Plasma |
3950B |
Prochlorperazine, Blood |
3950SP |
Prochlorperazine, Serum/Plasma |